Why the study?
Does the PRECISE-DAPT score predict in-hospital mortality in patients with STEMI undergoing pPCI?
Does the PRECISE-DAPT score predict in-hospital mortality in patients with STEMI undergoing pPCI?
The PRECISE-DAPT score is an independent predictor of in-hospital mortality in STEMI patients undergoing primary PCI, performing noninferiorly to the TIMI risk score.
Answers are grounded in this paper and cite their sources.
Supports PRECISE-DAPT association with STEMI in-hospital mortality; hypothesis-generating, requires prospective validation before adoption.
The PREdicting bleeding Complications In patients undergoing Stent implantation and subsEquent Dual Anti-Platelet Therapy (PRECISE-DAPT) score predicts the bleeding risk in patients treated with dual antiplatelet treatment after primary percutaneous coronary intervention (pPCI). This study aimed to determine the predictive value of the admission PRECISE-DAPT score for in-hospital mortality in patients with ST elevation myocardial infarction (STEMI) treated with pPCI. Of the 1418 patients enrolled, the study population was divided into 2 groups: PRECISE-DAPT score ≥25 and PRECISE-DAPT score <25. The primary goal was to determine the incidence of in-hospital all-cause mortality. In-hospital mortality was significantly higher in patients whose PRECISE-DAPT score ≥25 compared with the patients whose PRECISE-DAPT score <25 (9.4 vs 0.9%; P < .001, respectively). Both univariate and multivariate Cox proportional hazard analyses showed that the PRECISE-DAPT score is independently associated with in-hospital mortality (hazards ratio [HR]: 1.043, 95% confidence interval [CI]: 1.003-1.084; P = .035; and HR: 1.026, 95% CI: 1.004-1.048; P = .021, respectively). A pairwise comparison of receiver operating characteristic curves showed that the predictive value of the PRECISE-DAPT score with regard to in-hospital mortality was noninferior compared with the Thrombolysis in Myocardial Infarction risk score. The PRECISE-DAPT score may be a significant independent predictor of in-hospital mortality in patients with STEMI treated with pPCI.
No takes yet. Share an insight, caveat, or question.
Tanık et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: